Responders (CR/PR) exhibited robust cytotoxic T-cell activation characterized by up-regulation of GNLY, GZMB, and CXCL13, whereas non-responders (SD) uniquely showed persistent overexpression of HSPA1B, a stress-response gene associated with tumor progression and immune suppression. This evidence concerns the gene GZMB and neoplasm.